🇺🇸 Cabotegravir Injection [Apretude] in United States

Cabotegravir Injection [Apretude] (Cabotegravir Injection [Apretude]) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Cabotegravir Injection [Apretude] in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Cabotegravir Injection [Apretude] approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Cabotegravir Injection [Apretude] in United States?

University of Witwatersrand, South Africa is the originator. The local marketing authorisation holder may differ — check the official source linked above.